Home › Biocodex USA Acquires Totect, Antidote For Unintended Tissue Damage From Chemotherapy
 

Keywords :   


Biocodex USA Acquires Totect, Antidote For Unintended Tissue Damage From Chemotherapy

2013-04-02 09:00:00| drugdiscoveryonline News Articles

Biocodex USA announced recently its acquisition of the oncology supportive care product, Totect from Apricus Biosciences

Tags: usa damage tissue chemotherapy

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
27.09Summary for Remnants of John (EP5/EP102024)
27.09Tropical Storm Joyce Graphics
More »